SCHEMBL24796175

SCHEMBL24796175

CC1CCN(CCNC(=O)CSCC(=O)O)C(=O)C1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.44
▸ USP2 O75604 1/20 0.39
▸ FABP3 P05413 1/20 0.37
▸ FABP4 P15090 1/20 0.37
▸ PER2 O15055 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ CRY2 Q49AN0 1/20 0.34
▸ GAA P10253 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ MITF O75030 1/20 0.33
▸ KLF5 Q13887 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26746803 1.00 ALDH1A1 (0.44) ALDH1A1USP2FABP3FABP4PER2
SCHEMBL26746797 1.00 ALDH1A1 (0.44) ALDH1A1USP2FABP3FABP4PER2
SCHEMBL26634661 0.88 USP2 (0.37) ALDH1A1USP2FABP3FABP4KMT2A
SCHEMBL21389303 0.88 USP2 (0.37) ALDH1A1USP2FABP3FABP4KMT2A
SCHEMBL21383860 0.88 USP2 (0.37) ALDH1A1USP2FABP3FABP4KMT2A
SCHEMBL21384376 0.86 FABP3 (0.38) ALDH1A1USP2FABP3FABP4KMT2A
SCHEMBL21384374 0.86 FABP3 (0.38) ALDH1A1USP2FABP3FABP4KMT2A
SCHEMBL30131272 0.86 FABP3 (0.38) ALDH1A1USP2FABP3FABP4KMT2A
SCHEMBL21389487 0.86 FABP3 (0.38) ALDH1A1USP2FABP3FABP4KMT2A
SCHEMBL21389264 0.82 USP2 (0.40) ALDH1A1USP2FABP3FABP4PER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 — — US disclosed
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 — — US disclosed
US-11535660-B1 Modulators of G-protein coupled receptors Cannot Therapeutics, Inc. (US) 2022-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR ALDH1A1 3305/4885USP2 2595/4885FABP3 666/4885
US-11535660-B1 Modulators of G-protein coupled receptors GIPR, GLP1R, GCGR ALDH1A1 3367/4885USP2 2718/4885FABP3 669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback